Ss innovations reports first quarter 2025 financial results

Record quarterly revenue of $5.1 million driven by higher ssi mantra 3 unit sales on track for july 2025 de novo application to the fda for ssi mantra 3   fort lauderdale, fla., may 14, 2025 (globe newswire) -- ss innovations international, inc. (the “company” or “ss innovations”) (nasdaq: ssii), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three months ended march 31, 2025.
SSII Ratings Summary
SSII Quant Ranking